There's really no guide with ALS. If you were to look at 10 people with this disease in a line, I swear you wouldn't be able to tell whose progression is the fastest and whose is the slowest.

For ALS, where approved treatments remain woefully limited, this acceleration addresses the urgent need to find therapies that meaningfully slow disease progression. The HEALEY Platform Trial ...

“She was also a proud educator.” While she was unable to sing in her later years due to having ALS, a progressive disease that affects the brain and spinal cord, Flack remained creative in ...

Amyotrophic lateral sclerosis (ALS) is a neurological disease affecting a person’s nerve cells which are responsible for helping to control voluntary muscle movement. These muscles contract and ...

Though verdiperstat was estimated to slow progression by 2% versus placebo (95% credible interval -23% to 24%), it was unlikely to alter disease progression in ALS, according to Suma Babu ...

Tetramethylpyrazine nitrone was safe for people with amyotrophic lateral sclerosis (ALS), but neither a high nor low daily ...

Although the FDA has approved only two drugs for slowing ALS disease progression, there are an increasing number of options making their way through clinical trials 5. There may be nothing ...

A blood test can help doctors detect ALS, or amyotrophic lateral sclerosis, and predict how the degenerative disease will progress in patients, a new study suggests. People with ALS have three ...

Positron emission tomography (PET) is a nuclear imaging technique used to diagnose conditions such as cancer. An innovative advance from scientists at St. Jude Children's Research Hospital is ...